Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19.

"Financial Disclosure: 10.13039/501100005992M.E.S. reports receiving personal fees and grant support from 10.13039/100005294Massachusetts General Hospital, 10.13039/100006483AbbVie, 10.13039/100005564Gilead Sciences, and 10.13039/100004334Merck and has participated in scientific advisory boards for Gilead and as a scientific consultant to Bioporto, outside the submitted work. K.D.J. serves as a consultant for Astex Pharmaceuticals and Natera and receives fees from Uptodate.com outside of the submitted work. K.D.J. also receives honorarium from the International Society of Nephrology and American Society of Nephrology. V.B. receives honorarium from the International Society of Nephrology. M.A.S. is funded by a grant from Renal Research Institute. The other authors declare that they have no relevant financial interests."

"M.E.S. is supported by 10.13039/100000002National Institutes of Health (NIH) K23 DK 117014 and the Claflin Distinguished Scholars Award. The NIH had no role in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication. J.H.N. is supported by the Raggio and Hall Families. Figures 1 and 2 were created using Biorender.com."